{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:25:24Z","timestamp":1790220324368,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL136135"],"award-info":[{"award-number":["R01 HL136135"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA266556"],"award-info":[{"award-number":["R01 CA266556"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21 CA245594"],"award-info":[{"award-number":["R21 CA245594"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI135953-01"],"award-info":[{"award-number":["R01 AI135953-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.omtm.2023.101121","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T21:40:44Z","timestamp":1695678044000},"page":"101121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Efficient long-term multilineage engraftment of CD33-edited hematopoietic stem\/progenitor cells in nonhuman primates"],"prefix":"10.1016","volume":"31","author":[{"given":"Nicholas E.","family":"Petty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Radtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory J.","family":"Llewellyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George S.","family":"Laszlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland B.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5949-4947","authenticated-orcid":false,"given":"Hans-Peter","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2023.101121_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.blre.2014.04.001","article-title":"The past and future of CD33 as therapeutic target in acute myeloid leukemia","volume":"28","author":"Laszlo","year":"2014","journal-title":"Blood Rev."},{"key":"10.1016\/j.omtm.2023.101121_bib2","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood-2017-09-797712","article-title":"Gemtuzumab ozogamicin for acute myeloid leukemia","volume":"130","author":"Appelbaum","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2023.101121_bib3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/ijc.33865","article-title":"CD33-directed immunotherapy with third-generation chimeric antigen receptor T\u00a0cells and gemtuzumab ozogamicin in intact and CD33-edited acute myeloid leukemia and hematopoietic stem and progenitor cells","volume":"150","author":"Liu","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtm.2023.101121_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1309\/1WMW-CMXX-4WN4-T55U","article-title":"Differences in CD33 intensity between various myeloid neoplasms","volume":"118","author":"Jilani","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.omtm.2023.101121_bib5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41375-018-0277-8","article-title":"Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR\/Cas9-deletion of CD33 exon 2","volume":"33","author":"Humbert","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.omtm.2023.101121_bib6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cell.2018.05.013","article-title":"Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T\u00a0cell immunotherapy for acute myeloid leukemia","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2023.101121_bib7","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ymthe.2022.02.026","article-title":"Efficient polymer nanoparticle-mediated delivery of gene editing reagents into human hematopoietic stem and progenitor cells","volume":"30","author":"El-Kharrag","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.101121_bib30","doi-asserted-by":"crossref","first-page":"11978","DOI":"10.1073\/pnas.1819992116","article-title":"Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies","volume":"116","author":"Borot","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2023.101121_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1089\/crispr.2021.0052","article-title":"Pseudogene-mediated gene conversion after CRISPR-Cas9 editing demonstrated by partial CD33 conversion with SIGLEC22P","volume":"4","author":"Shaw","year":"2021","journal-title":"CRISPR J."},{"key":"10.1016\/j.omtm.2023.101121_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan1145","article-title":"A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates","volume":"9","author":"Radtke","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2023.101121_bib9","first-page":"296","article-title":"Transplantation and persistence of CRISPR\/Cas9-edited hematopoietic stem and progenitors cells for the reactivation of fetal hemoglobin in nonhuman primates (Abstract)","volume":"26","author":"Humbert","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.101121_bib28","series-title":"Laboratory Animal Medicine","first-page":"675","article-title":"Nonhuman Primates","author":"Bernacky","year":"2002"},{"key":"10.1016\/j.omtm.2023.101121_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw3768","article-title":"Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates","volume":"11","author":"Humbert","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2023.101121_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymthe.2021.06.016","article-title":"Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques","volume":"30","author":"AlJanahi","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.101121_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.7","article-title":"Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in\u00a0vivo selection after SHIV infection in a nonhuman primate model of AIDS","volume":"3","author":"Peterson","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.101121_bib13","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.bbmt.2017.08.038","article-title":"Relationship between mixed donor-recipient chimerism and disease recurrence after hematopoietic cell transplantation for sickle cell disease","volume":"23","author":"Abraham","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2023.101121_bib14","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood-2017-03-772392","article-title":"At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT","volume":"130","author":"Fitzhugh","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2023.101121_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/bbmt.2001.v7.pm11787529","article-title":"Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia","volume":"7","author":"Walters","year":"2001","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2023.101121_bib16","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1172\/JCI40767","article-title":"Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates","volume":"120","author":"Beard","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2023.101121_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.omtm.2017.11.005","article-title":"A nonhuman primate transplantation model to evaluate hematopoietic stem cell gene editing strategies for beta-hemoglobinopathies","volume":"8","author":"Humbert","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.101121_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41467-018-08201-x","article-title":"Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation","volume":"10","author":"Czechowicz","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2023.101121_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.omtm.2020.02.001","article-title":"Effective multi-lineage engraftment in a mouse model of Fanconi anemia using non-genotoxic antibody-based conditioning","volume":"17","author":"Srikanthan","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.101121_bib20","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1182\/blood.2021012366","article-title":"A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice","volume":"139","author":"Saha","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2023.101121_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40364-019-0175-x","article-title":"Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia","volume":"7","author":"Yu","year":"2019","journal-title":"Biomark. Res."},{"key":"10.1016\/j.omtm.2023.101121_bib22","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcyt.2019.03.585","article-title":"Optimization of CRISPR-Cas9 knock-out of CD33 in human hematopoietic stem\/progenitor cells for allogeneic transplantation in patients with acute myeloid leukemia","volume":"21","author":"Cummins","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omtm.2023.101121_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.omtm.2021.10.008","article-title":"Multiplex CRISPR\/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations","volume":"23","author":"Samuelson","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.101121_bib24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2217T to G\u2217C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2023.101121_bib25","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1182\/blood-2007-09-115022","article-title":"Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors","volume":"111","author":"Trobridge","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2023.101121_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/ajt.14006","article-title":"The knife's edge of tolerance: Inducing stable multilineage mixed chimerism but with a significant risk of CMV reactivation and disease in rhesus macaques","volume":"17","author":"Zheng","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.omtm.2023.101121_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13173","article-title":"Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy","volume":"7","author":"Adair","year":"2016","journal-title":"Nat. Commun."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123001602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123001602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T16:08:07Z","timestamp":1756138087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050123001602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":30,"alternative-id":["S2329050123001602"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2023.101121","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient long-term multilineage engraftment of CD33-edited hematopoietic stem\/progenitor cells in nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2023.101121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"101121"}}